Docetaxel-induced pericardial effusion

Dogan S. E., Mizrak D., Alkan A., DEMİRKAZIK A.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.23, sa.5, ss.389-391, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 5
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1177/1078155216643859
  • Dergi Adı: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.389-391
  • Anahtar Kelimeler: Docetaxel, pericardial effusion, side effect, INTRAVENOUS-INFUSION, CANCER-PATIENTS, BREAST-CANCER, PHASE-II, TRIAL
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Hypersensitivity reactions, cumulative fluid retention, and neurotoxicity are frequently seen toxicities related to docetaxel. Fluid retention may be present as edema, weight gain, or third place fluid collection. Pericardial effusion is rarely seen with docetaxel treatment. We report a 58-year-old female patient who was presented with pericardial tamponade after three cycles of docetaxel therapy.